SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-022757
Filing Date
2023-06-20
Accepted
2023-06-20 17:24:45
Documents
15
Period of Report
2023-06-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20230620.htm   iXBRL 8-K 32326
2 EX-99.1 a991ex062023.htm EX-99.1 6451
6 crdf-20230620_g1.jpg GRAPHIC 2732
7 image_0.jpg GRAPHIC 17928
  Complete submission text file 0001628280-23-022757.txt   195696

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230620.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230620_lab.xml EX-101.LAB 22877
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230620_pre.xml EX-101.PRE 12001
9 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230620_htm.xml XML 3937
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 231026457
SIC: 2836 Biological Products, (No Diagnostic Substances)